+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
ID07339111

Phase 3 Clinical Trial Comparing CARTISTEM Stem Cell Therapy and Debridement Surgery for Knee Cartilage Damage and Osteoarthritis

Led by Medipost, Inc. · Updated on 2026-10-29

300

Participants Needed

35

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating CARTISTEM, a new treatment made from stem cells derived from donated umbilical cord blood combined with a gel, to determine if it is safer and more effective than a standard surgical procedure called debridement for people with knee cartilage damage and osteoarthritis. This Phase 3 trial aims to show if CARTISTEM can reduce knee pain and improve function better than debridement two years after treatment. The study also investigates whether CARTISTEM may slow osteoarthritis progression using MRI scans. Participants will be divided into two groups one will receive CARTISTEM combined with debridement surgery, where the stem cell gel is placed into the damaged knee area after bone stimulation. The other group will undergo debridement surgery alone, which removes damaged cartilage and smooths the knee tissue. CARTISTEM involves mixing stem cells and a gel before placing it in the knee during surgery. Both groups will be monitored over two years. During the study, participants will have assessments of knee pain using the Visual Analog Scale and knee function using the WOMAC index from enrollment through 24 months. MRI scans will measure cartilage repair and osteoarthritis progression. Participants must follow rehabilitation requirements and limit other knee treatments during the trial. The study includes randomization and double-blinding to compare outcomes fairly while monitoring safety and effectiveness over time.

CONDITIONS

Brief Title

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Research Team

A

Adrian Orr, VP Clinical Development

L

Luis Toro, Medical Monitor for IQVIA, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here